Click Title for complete article or
click Summary for overview of each
article.
FDA
Approves Vaccines for the 2010-2011 Influenza
Season
From
Targeted News Service - Jul 31, 2010
The U.S. Department of Health and
Human Services' Food and Drug Administration
issued the following news release: Seasonal
influenza vaccine protects against three strains
of influenza, including the 2009 H1N1 influenza
virus, which caused the 2009
pandemic.
[ Summary
]
MCG
study emphasizes the impact of vitamin D [The
Augusta Chronicle, Ga.]
From Augusta Chronicle (GA) -
Jul 30,
2010
July 30--Asian
Brown could feel the difference when he started
taking vitamin D supplements, and the 16-year-old
student of A.R. Johnson Health Science and
Engineering Magnet School might be just the
beginning.
[ Summary
]
MCOs
Offering Both Medicare Advantage and Part D Plans
are More Than Twice as Likely to Cover Avastin and
Herceptin as a Drug Benefit on Their Medicare
Advantage Plans
From PharmaLive News Archive -
Jul 28,
2010
NASHVILLE,
Tenn. and Glen Rock, N.J., July 29 /PRNewswire/ --
HealthLeaders-InterStudy and Fingertip Formulary
find that surveyed pharmacy directors whose
managed care organizations offer both a Medicare
Advantage (MA) and a Part D plan were more than
twice as likely to cover Roche/Genentech/Chugai's
Avastin and Herceptin for the treatment of
multiple cancer indications as a drug benefit on
their MA plans as on their stand-alone Part D
plans.
[ Summary
]
| Genomics and
Biotechnology |
| Click Title for complete article or
click Summary for overview of each
article.
FDA:
Stem Cell Trial Can Proceed
From PharmaLive News Archive -
Aug 01,
2010
MENLO PARK,
Calif., July 31, 2010 (UPI) - The Food and Drug
Administration has given approval to proceed with
the world?s first human clinical trial of a human
embryonic stem cell-based therapy.
[ Summary
]
Adult
stem cell studies abound for heart, diabetes, MS;
far ahead of embryonic
research
From Canadian Press DataFile -
Aug 02,
2010
NEW YORK _ A
few months ago, Dr. Thomas Einhorn was treating a
patient with a broken ankle that would not heal,
even with multiple surgeries. Einhorn drew bone
marrow from the man's pelvic bone with a needle,
condensed it to about four teaspoons of rich red
liquid, and injected that into his ankle. Four
months later the ankle was healed. Einhorn's
experience is not a rigorous
study.
[ Summary
]
Geron
to Proceed with First Human Clinical Trial of
Embryonic Stem Cell-Based
Therapy
From
PharmaLive News Archive - Jul 29, 2010
MENLO PARK, Calif.--(BUSINESS
WIRE)--Jul 30, 2010 - Geron Corporation announced
today that the U.S. Food and Drug Administration
(FDA) has notified the company that the clinical
hold placed on Geron's Investigational New Drug
(IND) application has been lifted and the
company's Phase I clinical trial of GRNOPC1 in
patients with acute spinal cord injury may
proceed.
[ Summary
]
| FDA: New Treatments and
Technology |
| Click Title for complete article or
click Summary for overview of each
article.
FDA
Approves New Taxotere (docetaxel) Injection
Concentrate Formulation
From PharmaLive News Archive -
Aug 04,
2010
BRIDGEWATER,
N.J., Aug. 5 /PRNewswire/ -- Sanofi-aventis U.S.
announced today that the U.S. Food and Drug
Administration (FDA) has approved a new one-vial
formulation of its chemotherapeutic agent Taxotere
(docetaxel) Injection Concentrate.
[ Summary
]
FDA
Advisory Committee Recommended US FDA Approval of
Brilinta (Ticagrelor) for Acute Coronary
Syndromes
From PharmaLive News Archive -
Jul 27,
2010
WILMINGTON, DE
? July 28, 2010 ? AstraZeneca today announced that
the US Food and Drug Administration (FDA)
Cardiovascular and Renal Drugs Advisory Committee
recommended the FDA approve AstraZeneca?s
investigational drug ticagrelor for the reduction
of thrombotic events in patients with Acute
Coronary Syndromes (ACS).
[ Summary
]
FDA
Grants Priority Review to Cladribine Tablets for
the Treatment of Relapsing Forms of Multiple
Sclerosis
From PharmaLive News Archive -
Jul 27,
2010
Darmstadt,
Germany, July 28, 2010 - Merck KGaA announced
today that the U.S. Food and Drug Administration
(FDA) has accepted for filing the New Drug
Application (NDA) for Cladribine Tablets as a
therapy for relapsing forms of multiple sclerosis
(MS).
[ Summary
]
Click Title for complete article or
click Summary for overview of each
article.
Patients,
hospitals wrestle over tumor tissue [The
Philadelphia Inquirer]
From Philadelphia Inquirer (PA)
- Jul 29,
2010
July 29--All
Niki Perry wanted was pieces of her own brain, and
she got angrier by the day as she tried to get
them. She needed samples of her brain tumor this
spring to enter clinical trials she hoped might
save her life. What she got, she said, was delay
and disappointment.
[ Summary
]
New
England Journal of Medicine Publishes Data from
Pivotal Phase 3 PROVENGE IMPACT
Study
From
PR Newswire US - Jul
28, 2010
SEATTLE,
July 28 Dendreon Corporation announced today the
publication of data from the pivotal Phase 3
IMPACT study in the New England Journal of
Medicine, showing that PROVENGE® demonstrated a
statistically significant improvement in overall
survival compared to control in men with
asymptomatic or minimally symptomatic metastatic
castration resistant prostate
cancer.
[ Summary
]
CLICK THE FOLLOWING TITLES TO
PARTICIPATE IN THE ONLINE
CME/CEU
Inattention,
Hyperactivity and Impulsivity: The Diagnosis,
Management and Treatment of Behavioral Deficits
Attributed to ADHD
- Supported by an
educational grant from Ortho-McNeil Janssen
Scientific Affairs, LLC and Shire
Pharmaceuticals
Evolution
of Personalized Medicine: The Role of
Pharmacogenomics in Managed Care
-
Supported by an educational grant from Genzyme
Corporation
Effective
Diagnosis and Treatment of Early Parkinson?s
Disease
- Supported by an
educational grant from UCB Pharmaceuticals
| Journal of Managed Care
Medicine |
Your Logo
Here |
Journal of Managed Care
Medicine Vol 13, Issue 2 Table of
Contents
 Below
you will find the table of contents for the
current issue of JMCM. You can click
here to visit our main journal page, or
click on each individual article below to visit
their article page and then download the
PDF!
Click
the titles below to visit the indvidual article
download page.
Keys
to Detection of
VTE
Darrell W. Harrington,
MD, FACP
Understanding,
Diagnosing, and Managing
Fibromyalgia
Stuart
Silverman, MD, FACP FACR
Bipolar
Disorder: Developing a Cost Effective Management
Program
Jay Faber,
MD
Multiple
Myeloma: What Managed Care Needs to
Know
Laura Raftery,
MD
Targeted
Therapies in Non Small Cell Lung
Cancer
Ramaswamy Govindan,
MD
Optimizing
Patient Management: Improving Managed Care
Performance and Provider/Plan
Communication
Wendy J.
Evans, PhD, James D. Keller1, MD, and Mark I.
Evans, MD
Complete
13.2
Issue
| Join NAMCP's LinkedIn
Group! |
|
This is a GREAT way to network with other
members, send them direct messages, post comments
or questions and learn more about your colleagues
working in other areas of managed care! If you are
a member of this professional, social network,
please search groups for NAMCP and request to join
our group for ongoing discussions, networking and
interaction with other
members!
Visit NAMCP's Career
Center!
To find a job or fill a
position, visit http://careers.namcp.org.
You can also click on the links following each
individual job below to be taken to their new page
on our career center.
Job
seekers and employers have discovered the
advantages of searching online for the best jobs
and for qualified candidates to fill them. But,
the mass-market approach of the mega job boards
may not be your best avenue.
NAMCP's Career
Center gives employers and job seeking managed
care professionals a better way to find one
another and make that perfect career
fit.
For Job Seekers: Post your
resume; Search job listings; Set up Search Agents;
and have new postings sent to you via
email.
For Employers: Post your
jobs; Target a focused audience of candidates;
Search resumes; Track applications; Promote your
company online.
If you have an available position or have an
interest in our placement service, please contact
David Mara at (804)527-1905 or e-mail at dmara@namcp.org.
|
